Checking authentication...
Arch Pharmalabs Ltd Shares
Arch Pharmalabs Limited is a pharmaceutical company based in India, primarily engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (APIs) and intermediates. Business SegmentsArch Pharmalabs operates across two primary verticals:Products: This segment includes the manufacture and sale of APIs and intermediates to both innovator and generic pharmaceutical companies in domestic and international markets. The company offers over 120 products across various therapeutic segments such as oncology, anti-diabetic, anti-hypertensive, and more.Services: The services include Contract Research and Manufacturing Services (CRAMS), which encompass custom synthesis, process development, analytical development, and clinical trial manufacturing.Market PresenceArch Pharmalabs has established nine multipurpose manufacturing facilities equipped with modern technologies.The company has formed strategic alliances with international firms like Codexis (USA) and DSM (Netherlands) to enh...
Fundamentals
Financial (In Cr)
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 706 | 1309 | 1341 | - |
| Cost of Material Consumed | 444 | 1052 | 1062 | - |
| Gross Margins | 37.11 | 19.63 | 20.81 | - |
| Change in Inventory | 21 | -68 | -37 | - |
| Employee Benefit Expenses | 74 | 75 | 69 | - |
| Other Expenses | 892 | 73 | 67 | - |
| EBITDA | -725 | 177 | 180 | - |
| OPM | -102.69 | 13.52 | 13.42 | - |
| Other Income | 2853 | -1 | 1 | - |
| Finance Cost | 231 | 98 | 35 | - |
| D&A | 28 | 25 | 23 | - |
| EBIT | -753 | 152 | 157 | - |
| EBIT Margins | -106.66 | 11.61 | 11.71 | - |
| PBT | 1869 | 52 | 122 | - |
| PBT Margins | 264.73 | 3.97 | 9.1 | - |
| Tax (2021) | 0 | 0 | 0 | - |
| PAT | 1869 | 52 | 122 | - |
| NPM | 264.73 | 3.97 | 9.1 | - |
| EPS | 123.03 | 3.42 | 7.8 | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | -102.69 | 13.52 | 13.42 | - |
| Net Profit Margin | 264.73 | 3.97 | 9.1 | - |
| Earning Per Share (Diluted) | 123.03 | 3.42 | 7.8 | - |
Shareholding Pattern
| Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Arch Impex Private Limited | 0.3647 | 0.3647 | 0.2524 | - |
| JM Financial Asset Reconstruction Company Limited | 0.26 | 0.26 | 0.3541 | - |
| Arch Pharmachem Limited | 0.1394 | 0.1394 | 0.1354 | - |
| Others | 0.2359 | 0.2359 | 0.2581 | - |
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
